How to scale AI in healthcare: Deerfield and AWS collaboration

Healthcare organizations face a scaling gap between AI research and clinical deployment.

Life sciences investors and healthcare IT leaders struggle to move AI from pilot models into production workflows such as drug discovery, prior authorization, and case management. On November 9, 2026, Deerfield Management announced a collaboration with Amazon Web Services (AWS) to accelerate the development of AI-native healthcare and life sciences companies through agentic AI and cloud services. Softprom is the official partner of AWS.

What was announced

Deerfield Management, an investment firm focused on healthcare, will designate AWS as a preferred AI provider for the firm and selected portfolio companies. The scope combines AWS generative AI and cloud services with Deerfield Intelligence AI engineers and the Cure innovation ecosystem.

Deerfield Intelligence and Deerfield Discovery and Development (3DC) will receive AWS AI and cloud technology plus technical support to scale proprietary healthcare AI products. Selected portfolio companies will also gain access to AWS services, enablement, and training on large-scale model training, inference optimization, and healthcare-specific managed services.

This collaboration aims to drive the development of the next generation of AI-powered healthcare organizations

Why this matters

For CIOs, CISOs, and procurement leaders in healthcare and life sciences, the collaboration signals a validated reference architecture for deploying agentic AI in regulated environments. Ascertain, a Deerfield-backed healthcare technology company, already uses AWS services to automate case management and prior authorization workflows.

The Deerfield team includes more than 190 professionals, with 60+ MDs, JDs, and PhDs, headquartered at Cure in New York City. Joint programming at Cure is planned to activate the campus as a shared hub for the healthcare innovation community.

Technical details

• AI services: Amazon Bio Discovery for life sciences workloads
• Agentic AI: Amazon Bedrock AgentCore for building AI agents
• Workloads: drug discovery, operational automation, care delivery
• Enablement: training on large-scale model training and inference optimization
• Use case: Ascertain automates case management and prior authorization
• Status: AWS designated as preferred AI provider for Deerfield

FAQ

Which AWS services are involved?

Amazon Bio Discovery and Amazon Bedrock AgentCore are highlighted, alongside AWS cloud infrastructure, managed services, and technical enablement for healthcare-specific workloads.

Who benefits from the AWS collaboration with Deerfield?

Deerfield Intelligence, Deerfield Discovery and Development (3DC), and selected Deerfield portfolio companies across healthcare and life sciences, including Ascertain.

What workloads does this agentic AI platform target?

Drug discovery, operational automation, and care delivery, including clinical and administrative workflows such as case management and prior authorization.

Softprom and AWS

Softprom is the official partner of AWS. Access to AWS AI and cloud services for healthcare and life sciences projects is available via AWS.

Prepared by the Softprom editorial team based on vendor materials (Softprom DistriFlow). Source: original article.